Personalis at Neoantigen Summit Europe:  APR 24-26, 2018

Sean Michael Boyle, PhD
Director, Bioinformatics Applications
Personalis, Inc.

From Sample to Neoantigens for Vaccines:
Key Challenges and Solutions

Points that will be covered in his presentation:

• cfDNA neoantigens: dealing with tumor heterogeneity
• Improving neoantigen identification
• Elaborating TME, immuno-modulators and vaccine response biomarkers
• Overcoming poor sample quality and quantity for NGS sequencing
• Overcoming sequencing gaps that can harbor neoantigens
• Validation and regulatory issues on the way to commercialization